| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/22/2006 | EP0907378B1 Method for the concentration of antibody solutions |
| 02/22/2006 | EP0814837B2 Use of g class immunoglobulins for the topical treatment of atopic dermatitis |
| 02/22/2006 | EP0805871B2 Anti-cd30 antibodies preventing proteolytic cleavage and release of membrane-bound cd30 antigen |
| 02/22/2006 | EP0649537B2 Immunoassays for anti-hcv antibodies using antigens with conformational epitopes |
| 02/22/2006 | CN1739030A Diagnosis and prevention of cancer cell invasion |
| 02/22/2006 | CN1739029A Prion protein ligands and methods of use |
| 02/22/2006 | CN1738903A Immunization of fish with plant-expressed recombinant proteins |
| 02/22/2006 | CN1738901A Modular antigen transporter molecules (MAT molecules) for modulating immune reactions, associated constructs, methods and uses |
| 02/22/2006 | CN1738896A Composition and method for treating lupus nephritis |
| 02/22/2006 | CN1738834A Hcv 疫苗 Hcv vaccine |
| 02/22/2006 | CN1738833A Hcv疫苗 Hcv vaccine |
| 02/22/2006 | CN1738646A Designed deimmunized monoclonal antibodies for protection against HIV exposure and treatment of hiv infection |
| 02/22/2006 | CN1738645A Antilymphoma targeting agents with effector and affinity functions linked by a trifunctional reagent |
| 02/22/2006 | CN1738644A Gastrin compositions and methods of use and preparation |
| 02/22/2006 | CN1738643A Composition and method for preventing or treating a virus infection |
| 02/22/2006 | CN1738642A Method of obtaining conjugate vaccines and vaccine compositions containing same |
| 02/22/2006 | CN1738637A DC-SIGN blockers and their use for preventing or treating viral infections. |
| 02/22/2006 | CN1738635A Method of treating hepatitis virus infection with a multiphasic interferon delivery profile |
| 02/22/2006 | CN1738619A Administration of dendritic cells partially matured in vitro for the treatment of tumors |
| 02/22/2006 | CN1738618A Pharmaceutical compositions and their uses |
| 02/22/2006 | CN1738595A Composition comprising a prebiotic for decreasing inflammatory process and abnormal activation of non-specific immune parameters |
| 02/22/2006 | CN1737153A Recombinant bacillus Calmette-Guerin vaccine and its preparation method |
| 02/22/2006 | CN1737152A Recombinant Ag85B bacillus Calmette-Guerin vaccine |
| 02/22/2006 | CN1737144A Composite multiple epitope bivalent nucleic acid vaccine construction for foot-and-mouth disease |
| 02/22/2006 | CN1737011A Lymphoma specific chimeric monoclonal antibody against HLA-DR10 |
| 02/22/2006 | CN1736490A Tubercle bacillus chimeric gene vaccine and preparation process thereof |
| 02/22/2006 | CN1736483A Use of a CD40:CD154 binding interruptor to prevent counter adaptive immune responses, particularly graft rejection |
| 02/22/2006 | CN1736482A Recombined chicken pox virus vaccine rFPV-12LSH5H9, its construction method and use |
| 02/22/2006 | CN1736481A Recombined chicken pox virus vaccine rPFV-12LSH9A, preparation process and use thereof |
| 02/22/2006 | CN1736480A Method for preparing aftosa vaccine |
| 02/22/2006 | CN1736479A Prevention, treatment and detection of pig progressive atrophic rhinitis |
| 02/22/2006 | CN1736366A Preparation process and application of inorganic salt nanometer particle containing biological active material and enveloped Chinese medicinal ingredient |
| 02/22/2006 | CN1243097C Human ICAM-1 extramembranous I-III domain gene expression product ,its prep. and application in radioimmunological technology |
| 02/22/2006 | CN1242809C Applications of T-BAM (CD40L) technology in preparation of medicine to treat diseases involving smooth muscle cell |
| 02/22/2006 | CN1242750C Biodegradable and biocompatible polymeric microsphores encapsulating salmonella enteritidis bacteria |
| 02/21/2006 | US7002002 Vaccine against an infectious pathogen from Mycobacterium; 110-12 kd extracellular product proteins |
| 02/21/2006 | US7001995 Synthetic human papillomavirus genes |
| 02/21/2006 | US7001980 Monoclonal antibodies directed against the G3BP protein, and uses |
| 02/21/2006 | US7001890 Pharmaceutical compositions comprising a polynucleotide and optionally an antigen especially for vaccination |
| 02/21/2006 | US7001757 Protein |
| 02/21/2006 | US7001756 and hypercholesterolemia, atherosclerosis and coronary heart disease; dosage forms; use with Auricularia polytricha (wood ear), an edible fungi |
| 02/21/2006 | US7001744 Gene encoding an antigenic determinant of Escherichia coli is connected to a nontoxic cholera toxin A2 and B subunits (CTXA2B) gene of Vibrio cholerae; chimeric protein is useful as oral vaccine against uropathogenic E. coli with mild side effects |
| 02/21/2006 | US7001734 Process for identifying para cation channel modulators |
| 02/21/2006 | US7001718 Prevent complexing of Dna and ligand; viricides; drug mixture with carrier |
| 02/21/2006 | US7001602 Administering a neurotoxin ; therapy for enlargement of prostate gland |
| 02/21/2006 | US7001601 keyhole limpet hemocyanin (KLH) and adjuvant (QS-21; saponin derivative); immunogens; for treatment of melanomas |
| 02/21/2006 | US7001600 tyrosinase-related protein 2 (TRP-2); for treatment of metastatic melanomas |
| 02/21/2006 | US7001599 Nucleotide sequences coding polypeptide for use in the treatment of inflammatory defects |
| 02/21/2006 | US7001598 Administering lymphotoxin beta receptor-alpha/beta heteromeric complex and a pharmaceutically acceptable carrier for therapy or reducing the advancement, severity or effects of neoplasia |
| 02/21/2006 | US7001597 Methods for altering fertility |
| 02/21/2006 | CA2091181C Cloning of chicken anaemia dna |
| 02/21/2006 | CA2032381C Viral agent |
| 02/20/2006 | CA2478458A1 Treatment of pediatric multiple sclerosis |
| 02/20/2006 | CA2478455A1 Treatment of severe multiple sclerosis |
| 02/17/2006 | CA2478138A1 Cxcl10-based diagnosis and treatment of respiratory illnesses |
| 02/16/2006 | WO2006017856A2 Methods for constructing antibiotic resistance free vaccines |
| 02/16/2006 | WO2006017763A2 Capture and removal of biomolecules from body fluids using partial molecular imprints |
| 02/16/2006 | WO2006017759A2 Tumor endothelial marker-1 (tem1) binding antibodies and uses thereof |
| 02/16/2006 | WO2006017673A2 Taj in neuronal function |
| 02/16/2006 | WO2006017276A2 Recombinant rabies virus compositions |
| 02/16/2006 | WO2006016644A1 Antibody and utilization of the same |
| 02/16/2006 | WO2006015886A1 Angiogenic and immunologic applications of anti-cd160 specific compounds obtainable from mab cl1-r2 |
| 02/16/2006 | WO2006015775A2 Egfr kinase inhibitor combinations for treating respiratory and gastrointestinal disorders |
| 02/16/2006 | WO2006015557A1 Recombinant live fowlpox virus vectors and their use in pharmaceutical compositions against hepatitis c virus |
| 02/16/2006 | WO2005107803A3 Methods of determining the prognosis and treatment of subjects with lung cancer |
| 02/16/2006 | WO2005103082A3 Group 1 mite polypeptide variants |
| 02/16/2006 | WO2005077981A3 Fc POLYPEPTIDES WITH NOVEL Fc LIGAND BINDING SITES |
| 02/16/2006 | WO2005070959A3 Compositions comprising immune response altering agents and methods of use |
| 02/16/2006 | WO2005056574A3 Method and vaccine comprising copolymer 1 for treatment of psychiatric disorders |
| 02/16/2006 | WO2005048957A3 Novel insertion sites in pox vectors |
| 02/16/2006 | WO2004091510A3 Recombinant il-9 antibodies and uses thereof |
| 02/16/2006 | WO2004091491A3 Profiling conformational variants, antibody compositions and methods of using the same |
| 02/16/2006 | WO2004047720A3 Methods of inhibiting angiogensis via modification of a lysyl oxidase |
| 02/16/2006 | WO2003083058A3 Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
| 02/16/2006 | WO2003070164A3 Attenuated mycobacterium tuberculosis vaccines |
| 02/16/2006 | WO2003025129A3 Neurotransmission-associated proteins |
| 02/16/2006 | US20060037093 Transgenic transchromosomal rodents for making human antibodies |
| 02/16/2006 | US20060036086 Use of signal transduction inhibitors and combination therapies for the prevention or treatment of cancer and angiogenesis related diseases |
| 02/16/2006 | US20060036079 Surface protein of Leptospira |
| 02/16/2006 | US20060036070 Immunoglobulin a inducing protein and uses therefor |
| 02/16/2006 | US20060035907 Methods of treating abnormal cell growth using c-MET and m-TOR inhibitors |
| 02/16/2006 | US20060035856 Purified polypeptides having IL-13 receptor activity |
| 02/16/2006 | US20060035855 Purified polypeptides having IL-13 receptor activity |
| 02/16/2006 | US20060035853 Methods for tailoring the immune response to an antigen or immunogen |
| 02/16/2006 | US20060035851 Use of hmgb1 in the treatment of tissue damage and or to promote tissue repair |
| 02/16/2006 | US20060035839 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments |
| 02/16/2006 | US20060035825 Alpha 5 beta 1 and its ability to regulate the cell survival pathway |
| 02/16/2006 | US20060035813 Methods and formulations comprising agonists and antagonists of nuclear hormone receptors |
| 02/16/2006 | US20060035335 Use of HCV proteins |
| 02/16/2006 | US20060035328 Artery-and vein-specific proteins and uses therefor |
| 02/16/2006 | US20060035326 Genes |
| 02/16/2006 | US20060035324 BASB019 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses |
| 02/16/2006 | US20060035293 Antibodies, polypeptides and polynucleotides, used for detection, prevention and treatment of diseases caused by gramnegative bacteria |
| 02/16/2006 | US20060035284 Methods for isolating molecular mimetics of unique Neisseria meningitidis serogroup B epitopes |
| 02/16/2006 | US20060035267 Targets tumor specific antigens; antigens comprise GM2, fucosyl GM1, globo H and N-propionylated polysialic acid conjugated to immunomodulating carrier keyhole limpet hemocyanin, and adjuvant QS-21 or GPI-0100; optimal combination determined by cell surface reactivity; small cell lung cancer |
| 02/16/2006 | US20060035260 Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2 and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses |
| 02/16/2006 | US20060035246 Chromogenic in situ hybridization methods, kits, and compositions |
| 02/16/2006 | US20060035213 POSH nucleic acids, polypeptides and related methods |
| 02/16/2006 | US20060034955 Useful in increasing the effects of nucleic acid vaccines and medicaments; in production of phenotypically immature and/or mature dendritic and/or fibrocyte cells |
| 02/16/2006 | US20060034871 Immunogenic compositions for Chlamydia trachomatis |